Quantification and Stability Impact Assessment of Drop Stresses in Biologic Drug Products

References

1. 1.↵
   1. Rathore N.,
   2. Rajan R. S.

   Current Perspectives on Stability of Protein Drug Products during Formulation, Fill and Finish Operations. Biotechnol. Prog. 2008, 24 (3), 504–514.

   OpenUrlPubMed
2. 2.↵
   1. Vázquez-Rey M.,
   2. Lang D. A.

   Aggregates in Monoclonal Antibody Manufacturing Processes. Biotechnol. Bioeng. 2011, 108 (7), 1494–1508.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Nejadnik M. R.,
   2. Randolph T. W.,
   3. Volkin D. B.,
   4. Schöneich C.,
   5. Carpenter J. F.,
   6. Crommelin D. J. A.,
   7. Jiskoot W.

   Postproduction Handling and Administration of Protein Pharmaceuticals and Potential Instability Issues. J. Pharm. Sci. 2018, 107 (8), 2013–2019.

   OpenUrl
4. 4.↵
   1. Kiese S.,
   2. Papppenberger A.,
   3. Friess W.,
   4. Mahler H. C.

   Shaken, Not Stirred: Mechanical Stress Testing of an IgG1 Antibody. J. Pharm. Sci. 2008, 97 (10), 4347–4366.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Fradkin A. H.,
   2. Carpenter J. F.,
   3. Randolph T. W.

   Immunogenicity of Aggregates of Recombinant Human Growth Hormone in Mouse Models. J. Pharm. Sci. 2009, 98 (9), 3247–3264.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Ratanji K. D.,
   2. Derrick J. P.,
   3. Dearman R. J.,
   4. Kimber I.

   Immunogenicity of Therapeutic Proteins: Influence of Aggregation. J. Immunotoxicol. 2014, 11 (2), 99–109.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Bee J. S.,
   2. Stevenson J. L.,
   3. Mehta B.,
   4. Svitel J.,
   5. Pollastrini J.,
   6. Platz R.,
   7. Freund E.,
   8. Carpenter J. F.,
   9. Randolph T. W.

   Response of a Concentrated Monoclonal Antibody Formulation to High Shear. Biotechnol. Bioeng. 2009, 103 (5), 936–943.

   OpenUrlPubMed
8. 8.↵
   1. Li J.,
   2. Krause M. E.,
   3. Chen X.,
   4. Cheng Y.,
   5. Dai W.,
   6. Hill J. J.,
   7. Huang M.,
   8. Jordan S.,
   9. LaCasse D.,
   10. Narhi L.,
   11. Shalaev E.,
   12. Shieh I. C.,
   13. Thomas J. C.,
   14. Tu R.,
   15. Zheng S.,
   16. Zhu L.

   Interfacial Stress in the Development of Biologics: Fundamental Understanding, Current Practice, and Future Perspective. AAPS J. 2019, 21 (3), 44.

   OpenUrl
9. 9.↵
   1. Gikanga B.,
   2. Hui A.,
   3. Maa Y. F.

   Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations. PDA J. Pharm. Sci. Technol. 2018, 72 (2), 117–133.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Randolph T. W.,
    2. Schiltz E.,
    3. Sederstrom D.,
    4. Steinmann D.,
    5. Mozziconacci O.,
    6. Schöneich C.,
    7. Freund E.,
    8. Ricci M. S.,
    9. Carpenter J. F.,
    10. Lengsfeld C. S.

    Do Not Drop: Mechanical Shock in Vials Causes Cavitation, Protein Aggregation, and Particle Formation. J. Pharm. Sci. 2015, 104 (2), 602–611.

    OpenUrl
11. 11.↵
    1. Gikanga B.,
    2. Eisner D. R.,
    3. Ovadia R.,
    4. Day E. S.,
    5. Stauch O. B.,
    6. Maa Y. F.

    Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress. PDA J. Pharm. Sci. Technol. 2017, 71 (3), 172–188.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Nayak A.,
    2. Colandene J.,
    3. Bradford V.,
    4. Perkins M.

    Characterization of Subvisible Particle Formation during the Filling Pump Operation of a Monoclonal Antibody Solution. J. Pharm. Sci. 2011, 100 (10), 4198–4204.

    OpenUrlPubMed
13. 13.↵
    1. Rodrigues R. V.,
    2. Puryear M.,
    3. Sederstrom D.,
    4. Lengsfeld C. S. J.

    Parameters Influencing Cavitation within Vials Subjected to Drop Shock. Sci. Rep. 2019, 9 (1), 1–14.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Flannigan D. J.,
    2. Suslick K. S.

    Plasma Formation and Temperature Measurement during Single-Bubble Cavitation. Nature 2005, 434 (7029), 52–55.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Lauterborn W.,
    2. Ohl C. D.

    Cavitation Bubble Dynamics. Ultrason. Sonochem. 1997, 4 (2), 65–75. [Database]

    OpenUrlPubMed
16. 16.↵
    1. Ahsan H.,
    2. Ali A.,
    3. Ali R.

    Oxygen Free Radicals and Systemic Autoimmunity. Clin. Exp. Immunol. 2003, 131 (3), 398–404.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Duerkop M.,
    2. Berger E.,
    3. Dürauer A.,
    4. Jungbauer A.

    Impact of Cavitation, High Shear Stress and Air/Liquid Interfaces on Protein Aggregation. Biotechnol. J. 2018, 13 (7), e1800062.

    OpenUrl
18. 18.↵
    1. Duerkop M.,
    2. Berger E.,
    3. Dürauer A.,
    4. Jungbauer A.

    Influence of Cavitation and High Shear Stress on HSA Aggregation Behavior. Eng. Life Sci. 2018, 18 (3), 169–178.

    OpenUrl
19. 19.↵
    1. Treuheit M. J.,
    2. Kosky A. A.,
    3. Brems D. N.

    Inverse Relationship of Protein Concentration and Aggregation. Pharm. Res. 2002, 19 (4), 511–516.

    OpenUrlPubMed
20. 20.↵
    1. Hayashi H.,
    2. Akamine S.,
    3. Ichiki R.,
    4. Kanazawa S.

    Comparison of OH Radical Concentration Generated by Underwater Discharge Using Two Methods. Int. J. Plasma Environ. Sci. Technol. 2016, 10 (1), 24–28.

    OpenUrl
21. 21.↵
    1. Mason T. J.,
    2. Lorimer J. P.,
    3. Bates D. M.,
    4. Zhao Y.

    Dosimetry in Sonochemistry: The Use of Aqueous Terephthalate Ion as a Fluorescence Monitor. Ultrason. Sonochem. 1994, 1 (2), S91–S95.

    OpenUrl
22. 22.↵
    1. Ghime D.,
    2. Ghosh P.

    Kinetic Model for the Oxidative Degradation of Aqueous p-Nitrophenol by Fenton’s Reagent. J. Sci. Ind. Res. 2018, 77 (4), 208–212.

    OpenUrl
23. 23.↵
    1. Barreto J. C.,
    2. Smith G. S.,
    3. Strobel N. H.,
    4. McQuillin P. A.,
    5. Miller T. A.

    Terephthalic Acid: A Dosimeter for the Detection of Hydroxyl Radicals in Vitro. Life Sci. 1995, 56 (4), PL89–PL96.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Fleischman M. L.,
    2. Chung J.,
    3. Paul E. P.,
    4. Lewus R. A.

    Shipping-Induced Aggregation in Thera-peutic Antibodies: Utilization of a Scale-Down Model to Assess Degradation in Monoclonal Antibodies. J. Pharm. Sci. 2017, 106 (4), 994–1000.

    OpenUrl
25. 25.↵
    1. Torisu T.,
    2. Maruno T.,
    3. Yoneda S.,
    4. Hamaji Y.,
    5. Honda S.,
    6. Ohkubo T.,
    7. Uchiyama S.

    Friability Testing as a New Stress-Stability Assay for Biopharmaceuticals. J. Pharm. Sci. 2017, 106 (10), 2966–2978.

    OpenUrl
26. 26.↵
    1. Torisu T.,
    2. Maruno T.,
    3. Hamaji Y.,
    4. Ohkubo T.,
    5. Uchiyama S.

    Synergistic Effect of Cavitation and Agitation on Protein Aggregation. J. Pharm. Sci. 2017, 106 (2), 521–529.

    OpenUrl